SCHEMBL18617156

SCHEMBL18617156

Cc1cc(-c2cnc(N)c(C(N)=O)c2)ccc1C(=O)N1CCN(C)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3C3 Q8NEB9 3/20 0.59
▸ MERTK Q12866 3/20 0.56
▸ AXL P30530 2/20 0.56
▸ BMPR1B O00238 2/20 0.54
▸ BMPR1A P36894 2/20 0.54
▸ ACVRL1 P37023 2/20 0.54
▸ ACVR1 Q04771 2/20 0.54
▸ TGFBR1 P36897 1/20 0.54
▸ PIK3CB P42338 1/20 0.52
▸ KCNH2 Q12809 3/20 0.51
▸ LRRK2 Q5S007 1/20 0.49
▸ MET P08581 2/20 0.47
▸ MAP4K4 O95819 1/20 0.46
▸ JAK2 O60674 2/20 0.46
▸ FYN P06241 1/20 0.46
▸ PIK3CA P42336 1/20 0.45
▸ MTOR P42345 1/20 0.45
▸ JAK1 P23458 1/20 0.43
▸ TYK2 P29597 1/20 0.43
▸ JAK3 P52333 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18615504 0.87 BMPR1B (0.68) PIK3C3MERTKAXLBMPR1BBMPR1A
SCHEMBL18611892 0.83 MERTK (0.55) PIK3C3MERTKAXLPIK3CBMET
SCHEMBL18617157 0.82 FYN (0.66) PIK3C3MERTKAXLBMPR1BBMPR1A
SCHEMBL24319038 0.80 KCNH2 (0.67) PIK3C3MERTKAXLBMPR1BBMPR1A
SCHEMBL18615511 0.78 BMPR1B (0.62) PIK3C3MERTKAXLBMPR1BBMPR1A
SCHEMBL18616316 0.78 MERTK (0.57) PIK3C3MERTKAXLBMPR1BBMPR1A
SCHEMBL13515284 0.76 KCNH2 (0.56) MERTKAXLKCNH2LRRK2JAK2
SCHEMBL18616286 0.76 MERTK (0.55) PIK3C3MERTKAXLBMPR1BBMPR1A
SCHEMBL18615786 0.75 AXL (0.57) MERTKAXLBMPR1BBMPR1AACVRL1
SCHEMBL24838842 0.75 MERTK (0.74) MERTKAXLBMPR1BBMPR1AACVRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002353-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG A SOCIO HOLDINGS CO LTD (KR) 2023-01-05 — — US disclosed
EP-3344613-B1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG A SOCIO HOLDINGS CO LTD (KR) 2020-03-04 — — EP disclosed
WO-2017039331-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002353-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS MERTK, ERBB2, SRC PIK3C3 322/4885MERTK 1/4885AXL 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback